Trevi Therapeutics Statistics
NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.35-0.37 (-2.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Trevi Therapeutics by the numbers
Trevi Therapeutics has a market capitalization of $1.90 billion based on 142.56M shares outstanding. With trailing EPS of $-0.40, Trevi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.8% below its 50-day average and 8.5% below its 200-day average.
Average daily trading volume is 2.00M shares, or about $26.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRVI valuation vs. peer median
| Metric | TRVI | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.90B | $1.85B | +3% |
| Avg. volume | 2.00M | 1.23M | +63% |
Peer median across 8 companies: HRMY, BHVN, IMNM, VERA, AUPH, SEPN, MRVI, ZYME.
Valuation
- Market cap
- $1.90B
- EPS (TTM)
- $-0.40
- Shares outstanding
- 142.56M
Price and trading
- Previous close
- 13.72
- Open
- 13.58
- Day range
- 13.23 – 13.90
- 52-week range
- 9.82 – 20.22
- 52-week change
- +21.47%
- Beta
- —
- Volume
- 2.09M
- Average volume
- 2.00M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 1.90B
- Forward Pe
- -21.99
- Eps
- -0.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.22
- Week52 Low
- 9.82
- Avg Volume
- 2.00M
- Shares Outstanding
- 142.56M
- Ma50
- 13.73
- Ma200
- 14.58
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -33.98%
- Pct From52w Low
- 35.95%